Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2008 | 1 |
2012 | 2 |
2014 | 1 |
2016 | 1 |
2017 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Arbaclofen in fragile X syndrome: results of phase 3 trials.
J Neurodev Disord. 2017 Jun 12;9:3. doi: 10.1186/s11689-016-9181-6. eCollection 2017.
J Neurodev Disord. 2017.
PMID: 28616094
Free PMC article.
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, Scahill L, Cherubini M, Zarevics P, Walton-Bowen K, Carpenter RL, Bear MF, Wang PP, King BH.
Erickson CA, et al. Among authors: cherubini m.
J Autism Dev Disord. 2014 Apr;44(4):958-64. doi: 10.1007/s10803-013-1963-z.
J Autism Dev Disord. 2014.
PMID: 24272415
Clinical Trial.
Item in Clipboard
Metabolic and Pharmacokinetic Differentiation of STX209 and Racemic Baclofen in Humans.
Sanchez-Ponce R, Wang LQ, Lu W, von Hehn J, Cherubini M, Rush R.
Sanchez-Ponce R, et al. Among authors: cherubini m.
Metabolites. 2012 Sep 11;2(3):596-613. doi: 10.3390/metabo2030596.
Metabolites. 2012.
PMID: 24957649
Free PMC article.
Item in Clipboard
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial.
Veenstra-VanderWeele J, Cook EH, King BH, Zarevics P, Cherubini M, Walton-Bowen K, Bear MF, Wang PP, Carpenter RL.
Veenstra-VanderWeele J, et al. Among authors: cherubini m.
Neuropsychopharmacology. 2017 Jun;42(7):1390-1398. doi: 10.1038/npp.2016.237. Epub 2016 Oct 17.
Neuropsychopharmacology. 2017.
PMID: 27748740
Free PMC article.
Clinical Trial.
Item in Clipboard
Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway.
Ludwig K, Enker WE, Delaney CP, Wolff BG, Du W, Fort JG, Cherubini M, Cucinotta J, Techner L.
Ludwig K, et al. Among authors: cherubini m.
Arch Surg. 2008 Nov;143(11):1098-105. doi: 10.1001/archsurg.143.11.1098.
Arch Surg. 2008.
PMID: 19015469
Clinical Trial.
Item in Clipboard
Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, Mu Y, Nguyen DV, Gonzalez-Heydrich J, Wang PP, Carpenter RL, Bear MF, Hagerman RJ.
Berry-Kravis EM, et al. Among authors: cherubini m.
Sci Transl Med. 2012 Sep 19;4(152):152ra127. doi: 10.1126/scitranslmed.3004214.
Sci Transl Med. 2012.
PMID: 22993294
Clinical Trial.
Item in Clipboard
Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.
Paulson DM, Kennedy DT, Donovick RA, Carpenter RL, Cherubini M, Techner L, Du W, Ma Y, Schmidt WK, Wallin B, Jackson D.
Paulson DM, et al. Among authors: cherubini m.
J Pain. 2005 Mar;6(3):184-92. doi: 10.1016/j.jpain.2004.12.001.
J Pain. 2005.
PMID: 15772912
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite